Physician profile
Daniel M Zinar
NPI 1720074461
$6,409.94
in general payments reported to CMS, 2019-2025
7 companies · $443 in 2025
The $443 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,021 · 2021: $1,839 · 2022: $2,094 · 2023: $351 · 2024: $662 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,942.45 | 2021-2025 | Variax, Gamma, T2 Alpha |
| Smith+Nephew, INC. | $1,998.95 | 2019-2022 | |
| Depuy Synthes Sales INC. | $240.50 | 2021-2025 | Na |
| Globus Medical, INC. | $150.62 | 2022-2025 | Autobahn, Troch Nail, Evo Retrograde |
| Dynasplint Systems INC. | $35.97 | 2021 | |
| Acera Surgical, INC. | $24.96 | 2024 | Restrata Wound Matrix |
| Sanofi-Aventis U.S. LLC | $16.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Zinar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.